MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Greatbatch proposes to mostly exit Switzerland for Indiana, Mexico | Wall Street Beat

Greatbatch proposes to mostly exit Switzerland for Indiana, Mexico | Wall Street Beat

By

MassDevice.com Wall Street Beat

Greatbatch (NYSE:GB) said it wants to largely shutter a pair of plants in Switzerland and relocate their operations to Ft. Wayne, Ind., and Tijuana, Mexico.

The Clarence, N.Y.-based company said the slumping orthopedics market and downward pricing pressures are precipitating the move, which is expected to affect 90% of the 196 workers at the plants in Orvin and Corgemont, Switzerland – or about 176 employees.

Under Swiss law, Greatbatch must provide a comment period for employees before putting the plan in motion. The Swiss workers have until July 20 to give their input; the company is hoping to execute the move by the end of 2013.

Sign up to get our free newsletters delivered straight to your inbox

"The presentation of this plan follows particularly difficult orthopaedics market conditions since Precimed became part of Greatbatch. Beyond the economic slowdown immediately following the acquisition, customers have started to put more and more emphasis on product pricing as well as slowed down the rate at which they launch major joint replacement programs," according to a press release. "The company remains committed to the global and European orthopaedics markets, with the proposed structure being even more capable of meeting customer design and technical support needs. A limited number of sales, administrative and technical roles would likely remain in Switzerland, aligned with Greatbatch Medical’s regional operating model."

"This consolidation would optimize utilization of our existing operating infrastructure while enhancing the overall competitiveness of the business. The resulting cost savings would permit continuous investments in both our commercial strategy and medical device innovations," president Mauricio Arellano said in prepared remarks. "We are intensely focused on growth in our core business, growth through targeted acquisitions and growth through new, innovative medical devices. Our intention to relocate select production to more highly-efficient sites would be yet another step toward our vision of developing complete medical systems and devices."

 ThermoGenesis sells CryoSeal to Asahi Kasei

Japanese conglomerate Asahi Kasei (TYO:3407) is on a tear through the U.S. medical device market. Hard on the heels of its $YY billion buyout of Zoll Medical, Asahi Kasei is picking up its option on ThermoGenesis Corp.’s (NSDQ:KOOL)
CryoSeal fibrin wound sealant for $2 million. Read more

 Masimo, PSS World Medical ink Pronto-7 distribution deal

Masimo (NSDQ:MASI) inked a distribution deal for its hand-held Pronto-7 patient monitor with PSS World Medical (NSDQ:PSSI). Read more

 Digirad dodges proxy war

Digirad Corp. (NSDQ:DRAD) said it agreed to alter its bylaws and corporate structure to avoid a proxy war with activist investor the Red Oak Group. Read more

 NASDAQ warns Escalon Medical on possible de-listing
Escalon Medical (NSDQ:ESMC) said the NASDAQ stock exchange warned it of a possible de-listing if it can’t get its stock price back above the exchange’s $`-per-share minimum requirement. ESMC shares were trading at 69¢ apiece as of about 11:15 a.m. today. Read more

 Mergers & Acquisitions News

Read more

 Analysts’ ups and downs

  • AtriCure (NSDQ:ATRC): Piper Jaffray reiterates "overweight" rating, lowers price target from $14 to $12.
  • C.R. Bard (NYSE:BCR): Piper Jaffray reiterates "neutral" rating, increases price target from $92 to $102.
  • Cutera (NSDQ:CUTR): Piper Jaffray reiterates "overweight" rating, lowers price target from $12 to $10.
  • Haemonetics (NYSE:HAE): Sidoti downgrades to "neutral" from Buy.
  • Hansen Medical (NSDQ:HNSN): Piper Jaffray reiterates "overweight" rating, lowers price target from $5 to $4.
  • HeartWare International (NSDQ:HTWR): Piper Jaffray reiterates "neutral" rating, raises price target from $80 to $88.
  • Insulet (NSDQ:PODD): Canaccord Genuity reaffirms “buy” rating.

In case you missed it

RSS From Medical Design & Outsourcing

  • Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future
    All eyes are on Medtronic’s global operations and supply chain leader as he works to modernize its operations and scrutinize suppliers. EVP of Global Operations and Supply Chain Greg Smith anticipates fewer suppliers in Medtronic’s future, he said in an interview this week. Smith spoke with DeviceTalks Editorial Director Tom Salemi in his first published… […]
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
    CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people with diabetes. When it comes to managing diabetes, CeQur wants to make insulin therapy as convenient as possible. For those who prefer to manage their own insulin delivery, the Simplicity device might just do exactly that. Simplicity, a wearable, disposable… […]
  • Meddux opens new facility in Colorado
    Engineering, design, development and manufacturing company Meddux announced that it opened a new facility in Boulder, Colorado. The new, 22,000-square-foot facility doubles the overall square footage from its previous location in Colorado. According to a news release, it helps the company to quadruple its product development area and double its manufacturing footprint. Meddux’s new facility… […]
  • Reducing the Overall Cost of Validation
    By PTI Engineered Plastics Reliable medical devices and equipment are essential for researchers and doctors to accurately diagnose and treat a wide range of diseases. That is why there is such stringent oversight from the FDA to ensure these products meet the necessary requirements and specifications. To ensure compliance with regulators, manufacturers follow installation qualification… […]
  • BBS Automation has a deal to buy medtech supplier Kahle Automation
    BBS Automation said it plans to purchase high-speed automation supplier Kahle Automation to expand its medtech and life sciences business. Kahle will operate as Kahle – a BBS Company, according to a news release from Munich, Germany-based BBS and Lombardy, Italy-based Kahle. The deal is subject to regulatory approval. Terms were not disclosed. Kahle’s co-owners —… […]
  • How safe is health information after the overturning of Roe?
    The U.S. Department of Health and Human Services today issued guidance meant to better protect women’s health information as state abortion bans kick in after the U.S. Supreme Court’s overturning of Roe v. Wade. Despite the HHS actions, women may still wonder whether their health information is entirely safe going forward — a potential challenge… […]
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge
    New evidence is showing that COVID-19 may increase a person’s risk of diabetes, but it could be years until we know for sure. In the meantime, Dexcom (Nasdaq:DXCM) is getting ready, VP of Global Clinical Initiatives Tomas Walker said. Walker recently spoke with Medical Design & Outsourcing to discuss the San Diego-based diabetes device developer’s… […]
  • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
    Blackrock Neurotech and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL) are working together on the first portable brain-computer interface (BCI) to allow patients to participate in research trials from home. A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year. Salt… […]
  • How medical device companies are responding to abortion bans
    Days after the U.S. Supreme Court’s decision to overturn Roe v. Wade’s protection of abortion rights, medical device companies are among those reassuring workers about healthcare access. Corporate communications to employees and the public at large come as trigger laws in nearly half of the states outlaw abortion immediately. Some medtech companies are not using… […]
  • Philips updates on testing results for recalled ventilators
    Royal Philips (NYSE:PHG) says only a small portion of returned respiratory devices displayed the sound abatement foam degradation that sparked a massive recall. Repeated ozone cleaning may have made the problem worse. Those were some of the major takeaways from an update Philips provided today on a comprehensive test and research program it implemented after its… […]
  • ResMed names Lucile Blaise as new Sleep & Respiratory Care leader
    Lucile Blaise will be the new president of ResMed’s Sleep & Respiratory Care business starting July 1, ResMed (NYSE: RMD) said today. She replaces Jim Hollingshead, who became president and CEO of Insulet (Nasdaq:PODD) on June 1. ResMed President and COO Rob Douglas is serving as interim president of the Sleep & Respiratory Care during… […]

Leave a Reply